Form 4: Mirum CEO Peetz Donates Shares to Charitable Fund

Mirum Pharmaceuticals CEO Christopher Peetz reported a gift of 21,070 shares of common stock to a charitable donor-advised fund.

Summary

• Christopher Peetz, Chief Executive Officer and Director of Mirum Pharmaceuticals, Inc. (MIRM), reported a change in beneficial ownership.
• On December 31, 2025, Peetz donated 21,070 shares of Mirum Pharmaceuticals Common Stock.
• The donation was made as a bona fide gift to a charitable donor-advised fund.
• Following this transaction, Peetz directly owns 158,034 shares of Common Stock.
• An additional 187,500 shares are indirectly owned by The Peetz Family Trust.

Sentiment

Score: 6

Explanation: The filing reports a charitable gift of shares by the CEO, which is a neutral event for the company's operations but reflects positively on the individual's philanthropy.

Positives

• CEO Christopher Peetz made a significant charitable donation of company stock, reflecting personal philanthropy.

Future Outlook

NA

Industry Context

This filing reports a routine insider transaction and does not provide information related to broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: The transaction represents a change in beneficial ownership by a key executive and is a routine disclosure. It does not indicate any operational changes or significant financial impact on the company.
• Charitable Organizations: The recipient donor-advised fund will benefit from the gifted shares.

Key Dates

Recommendation

This Form 4 filing reports a routine insider transaction (a charitable gift of shares) and does not contain information that would warrant a change in investment recommendation for Mirum Pharmaceuticals. The transaction is a personal financial decision of the CEO and does not reflect on the company's operational performance or future prospects.

Keywords

Mirum Pharmaceuticals, MIRM, Form 4, insider transaction, stock gift, CEO, beneficial ownership, charitable donation